Kevin Wightman, MAICD

Kevin Wightman is an accomplished leader in the clinical research sector, currently serving as the Head of Strategy and Solutions for Asia Pacific at Catalyst Clinical Research since April 2023. Wightman also holds the position of Non-Executive Director at Aotearoa Clinical Trials and has extensive consulting experience as the Director at Tegra Biopharma Consulting, specializing in strategic business development and decentralized trials. Other notable roles include Chief Strategy Officer at Neuroscience Trials Australia, Senior Director of Business and Corporate Development at Illingworth Research Group, and Executive Director at Nucleus Network. Wightman's significant contributions to the Australian clinical research ecosystem are further evidenced through tenure as a Board Director of ARCS Australia and previous leadership roles in various prominent organizations. An alumnus of the University of Nottingham with a BSc (Hons) in Chemistry and Pharmacology, Wightman is also a graduate of the Global Leadership Program.